0002138776-26-000001.txt : 20260701 0002138776-26-000001.hdr.sgml : 20260701 20260701104234 ACCESSION NUMBER: 0002138776-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260701 DATE AS OF CHANGE: 20260701 EFFECTIVENESS DATE: 20260701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Andros Medicines Inc. CENTRAL INDEX KEY: 0002138776 ORGANIZATION NAME: EIN: 415084809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-589259 FILM NUMBER: 261143262 BUSINESS ADDRESS: STREET 1: 1 FRANKLIN STREET, #PH2B CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6174809731 MAIL ADDRESS: STREET 1: 1 FRANKLIN STREET, #PH2B CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0002138776 Andros Medicines Inc. 1 FRANKLIN STREET, #PH2B BOSTON MA MASSACHUSETTS 02110 6178756106 DELAWARE None None Corporation true 2026 John Maraganore c/o Andros Medicines Inc. 1 Franklin Street, #PH2B Boston MA MASSACHUSETTS 02110 Executive Officer Director Khalil Barrage c/o Andros Medicines Inc. 1 Franklin Street #PH2B Boston MA MASSACHUSETTS 02110 Director Antoine Barouky c/o Andros Medicines Inc. 1 Franklin Street, #PH2B Boston MA MASSACHUSETTS 02110 Director Pharmaceuticals Decline to Disclose 06b false 2026-06-18 false true false 0 5049999 3049999 2000000 false 2 0 0 0 false Andros Medicines Inc. /s/ John Maraganore John Maraganore President and CEO 2026-06-30